MaxCyte (MXCT) Competitors $3.01 -0.14 (-4.48%) As of 12:30 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MXCT vs. SEZL, XMTR, FLYW, NEO, DFIN, TASK, NVEE, EVH, CTOS, and OLOShould you be buying MaxCyte stock or one of its competitors? The main competitors of MaxCyte include Sezzle (SEZL), Xometry (XMTR), Flywire (FLYW), NeoGenomics (NEO), Donnelley Financial Solutions (DFIN), TaskUs (TASK), NV5 Global (NVEE), Evolent Health (EVH), Custom Truck One Source (CTOS), and OLO (OLO). These companies are all part of the "business services" industry. MaxCyte vs. Sezzle Xometry Flywire NeoGenomics Donnelley Financial Solutions TaskUs NV5 Global Evolent Health Custom Truck One Source OLO MaxCyte (NASDAQ:MXCT) and Sezzle (NASDAQ:SEZL) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, community ranking, institutional ownership, dividends, analyst recommendations, risk and earnings. Which has stronger valuation and earnings, MXCT or SEZL? Sezzle has higher revenue and earnings than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than Sezzle, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMaxCyte$38.63M8.65-$37.92M-$0.39-8.08Sezzle$271.13M5.26$7.10M$13.1019.31 Do analysts recommend MXCT or SEZL? MaxCyte presently has a consensus target price of $8.67, indicating a potential upside of 175.13%. Sezzle has a consensus target price of $368.50, indicating a potential upside of 45.70%. Given MaxCyte's higher probable upside, equities research analysts clearly believe MaxCyte is more favorable than Sezzle.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MaxCyte 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Sezzle 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has more volatility & risk, MXCT or SEZL? MaxCyte has a beta of 1.35, suggesting that its share price is 35% more volatile than the S&P 500. Comparatively, Sezzle has a beta of 9.09, suggesting that its share price is 809% more volatile than the S&P 500. Does the media favor MXCT or SEZL? In the previous week, MaxCyte had 4 more articles in the media than Sezzle. MarketBeat recorded 7 mentions for MaxCyte and 3 mentions for Sezzle. Sezzle's average media sentiment score of 0.72 beat MaxCyte's score of 0.35 indicating that Sezzle is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MaxCyte 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sezzle 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in MXCT or SEZL? 68.8% of MaxCyte shares are held by institutional investors. Comparatively, 2.0% of Sezzle shares are held by institutional investors. 3.0% of MaxCyte shares are held by insiders. Comparatively, 57.7% of Sezzle shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community prefer MXCT or SEZL? MaxCyte received 2 more outperform votes than Sezzle when rated by MarketBeat users. However, 100.00% of users gave Sezzle an outperform vote while only 80.00% of users gave MaxCyte an outperform vote. CompanyUnderperformOutperformMaxCyteOutperform Votes1280.00% Underperform Votes320.00% SezzleOutperform Votes10100.00% Underperform VotesNo Votes Is MXCT or SEZL more profitable? Sezzle has a net margin of 25.29% compared to MaxCyte's net margin of -78.36%. Sezzle's return on equity of 101.18% beat MaxCyte's return on equity.Company Net Margins Return on Equity Return on Assets MaxCyte-78.36% -16.00% -13.93% Sezzle 25.29%101.18%18.90% SummarySezzle beats MaxCyte on 13 of the 19 factors compared between the two stocks. Remove Ads Get MaxCyte News Delivered to You Automatically Sign up to receive the latest news and ratings for MXCT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MXCT vs. The Competition Export to ExcelMetricMaxCyteCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$333.99M$3.64B$5.74B$8.28BDividend YieldN/A2.02%4.55%4.02%P/E Ratio-9.26110.1724.7419.36Price / Sales8.65121.74393.1193.27Price / CashN/A34.5738.1634.64Price / Book1.412.727.164.51Net Income-$37.92M$113.28M$3.20B$247.14M7 Day Performance-1.25%-4.63%2.86%3.64%1 Month Performance-12.98%-19.81%7.01%-2.30%1 Year Performance-27.59%-9.51%15.61%4.93% MaxCyte Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MXCTMaxCyte2.6926 of 5 stars$3.01-4.5%$8.67+188.0%-28.7%$322.86M$38.63M-8.9680SEZLSezzle3.5809 of 5 stars$235.00+1.1%$368.50+56.8%+237.2%$1.33B$271.13M25.00540XMTRXometry3.6351 of 5 stars$25.70+3.6%$36.11+40.5%+58.3%$1.29B$545.53M-24.48790Positive NewsFLYWFlywire4.3726 of 5 stars$10.45-0.9%$19.23+84.0%-58.9%$1.29B$492.14M69.67660Analyst ForecastNEONeoGenomics3.2103 of 5 stars$9.84+0.2%$19.60+99.2%-33.2%$1.26B$660.57M-15.872,100DFINDonnelley Financial Solutions3.7348 of 5 stars$43.91+1.4%$71.33+62.5%-25.6%$1.26B$781.90M14.352,150Positive NewsTASKTaskUs2.6682 of 5 stars$13.46-1.5%$17.25+28.2%+15.3%$1.21B$994.99M22.8148,200NVEENV5 Global3.671 of 5 stars$18.22+0.2%$25.67+40.9%-20.8%$1.19B$941.27M36.993,640News CoveragePositive NewsEVHEvolent Health2.6463 of 5 stars$9.96+5.8%$17.71+77.9%-70.1%$1.16B$2.55B-12.145,100Positive NewsCTOSCustom Truck One Source1.6268 of 5 stars$4.73+1.2%$5.88+24.3%-6.1%$1.07B$1.80B-29.532,580OLOOLO3.1859 of 5 stars$6.21-0.5%$8.67+39.6%+25.8%$1.03B$284.94M-62.08710 Remove Ads Related Companies and Tools Related Companies Sezzle Alternatives Xometry Alternatives Flywire Alternatives NeoGenomics Alternatives Donnelley Financial Solutions Alternatives TaskUs Alternatives NV5 Global Alternatives Evolent Health Alternatives Custom Truck One Source Alternatives OLO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MXCT) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MaxCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MXCT Stock Free MXCT Stock Alerts